Cuizon, Yvette A.
HRN: 24-18-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2023
CEFTAZIDIME 1GM (VIAL)
11/29/2023
12/05/2023
IV
2gram
Q8hrs
Infected Wound, Left, Foot
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes